CenterBook Partners’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$300K Sell
2,918
-8,207
-74% -$927K 0.02% 558
2025
Q4
$1.39M Buy
+11,125
New +$1.42M 0.07% 325
2025
Q2
Sell
-10,467
Closed -$1.39M 494
2025
Q1
$1.39M Buy
+10,467
New +$1.33M 0.09% 256
2023
Q1
Sell
-17,757
Closed -$1.95M 382
2022
Q4
$1.95M Buy
17,757
+7,922
+81% +$820K 0.32% 104
2022
Q3
$952K Buy
9,835
+1,674
+21% +$178K 0.18% 187
2022
Q2
$887K Buy
8,161
+5,934
+266% +$674K 0.19% 188
2022
Q1
$264K Buy
+2,227
New +$276K 0.09% 296

Other funds holding ABT

CenterBook Partners's ABT Position: Q1 2026 in Review

CenterBook Partners reduced its Abbott (ABT) stake by 74% in Q1 2026, selling an estimated $927K and leaving 2,918 shares worth $300K. The position accounts for 0.02% of the portfolio, ranked #558.

CenterBook Partners first reported a position in ABT in Q1 2022 and has held it in 7 quarters since. The position peaked at $1.95M in Q4 2022. 3,089 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • CenterBook Partners held 2,918 shares of Abbott worth $300K as of Q1 2026.
  • CenterBook Partners sold 8,207 Abbott shares in Q1 2026, an estimated $927K.
  • Abbott made up 0.02% of CenterBook Partners's portfolio in Q1 2026, its #558 holding.
  • CenterBook Partners first reported a position in Abbott in Q1 2022 and has held it in 7 quarters since.
  • CenterBook Partners's Abbott position peaked at $1.95M in Q4 2022.
  • 3,089 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on CenterBook Partners's 13F filing for Q1 2026, filed 5 May 2026.